ATUM (formerly DNA2.0, Inc.) has signed a patent licensing agreement that gives Thermo Fisher Scientific access to certain systems and methods for gene design as described in United States Patent No. 7,805,202.
“Most people think visually, so seeing a graphic representation of a sequence is very helpful in the design process,” said Alan Villalobos, ATUM’s Vice President of Synthetic Biology and an inventor of the method.
“This patent family is directed to representing sequence elements as icons, and features a drag and drop function that is crucial for avoiding errors that creep in during cut-and-paste operations, when one nucleotide missed can destroy the function of the entire construct. We are delighted that Thermo Fisher is utilising these features.”